Ernexa Therapeutics, Inc. (ERNA)
2.34
-0.15
(-6.02%)
USD |
NASDAQ |
Oct 09, 16:00
2.34
0.00 (0.00%)
After-Hours: 20:00
Ernexa Therapeutics Price to Book Value : 0.8558 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 0.9107 |
| October 07, 2026 | 0.8741 |
| October 06, 2026 | 0.8174 |
| October 05, 2026 | 0.9875 |
| October 02, 2026 | 1.083 |
| October 01, 2026 | 1.083 |
| September 30, 2026 | 1.170 |
| September 29, 2026 | 1.156 |
| September 28, 2026 | 1.269 |
| September 25, 2026 | 1.26 |
| September 24, 2026 | 1.324 |
| September 23, 2026 | 1.335 |
| September 22, 2026 | 1.390 |
| September 21, 2026 | 1.448 |
| September 18, 2026 | 1.401 |
| September 17, 2026 | 1.375 |
| September 16, 2026 | 1.43 |
| September 15, 2026 | 1.492 |
| September 14, 2026 | 1.562 |
| September 11, 2026 | 1.523 |
| September 10, 2026 | 1.470 |
| September 09, 2026 | 1.470 |
| September 08, 2026 | 1.532 |
| September 04, 2026 | 1.576 |
| September 03, 2026 | 1.657 |
| Date | Value |
|---|---|
| September 02, 2026 | 1.660 |
| September 01, 2026 | 1.591 |
| August 31, 2026 | 1.671 |
| August 28, 2026 | 1.671 |
| August 27, 2026 | 1.732 |
| August 26, 2026 | 1.788 |
| August 25, 2026 | 1.801 |
| August 24, 2026 | 1.842 |
| August 21, 2026 | 1.778 |
| August 20, 2026 | 1.653 |
| August 19, 2026 | 1.620 |
| August 18, 2026 | 1.554 |
| August 17, 2026 | 1.485 |
| August 14, 2026 | 1.562 |
| August 13, 2026 | 1.573 |
| August 12, 2026 | 1.617 |
| August 11, 2026 | 1.606 |
| August 10, 2026 | 1.657 |
| August 07, 2026 | 1.540 |
| August 06, 2026 | 1.595 |
| August 05, 2026 | 1.500 |
| August 04, 2026 | 1.617 |
| August 03, 2026 | 1.262 |
| July 31, 2026 | 1.200 |
| July 30, 2026 | 1.269 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cerenome, Inc. | 2.583 |
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.96 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.042 |
Price to Book Value Related Metrics
| Price | 2.34 |
| Earnings Yield | -808.7% |
| Market Cap | 2.738M |